Delivering Antibacterials to the Lungs

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Respiratory Medicine

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF03256617PMID 14720046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Penetration of Ofloxacin from Blood to Sputum

  2012cited by this paper
• Pharmacokinetics and Pharmacodynamics of Fluoroquinolones

  2012cited by this paper
• Pulmonary Disposition of Lomefloxacin in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. A Multiple-Dose Study

  2001cited by this paper
• What have we learned from pharmacokinetic and pharmacodynamic theories?

  2001cited by this paper
• Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.

  2001cited by this paper
• Fluoroquinolone pharmacodynamics. Authors' reply

  2001cited by this paper
• Lung concentrations of telithromycin after oral dosing.

  2001cited by this paper
• Fluoroquinolone pharmacodynamics.

  2001cited by this paper
• Interrelationship Between the Pharmacokinetics and Pharmacodynamics of Cefaclor Advanced Formulation in Patients with Acute Exacerbations of Chronic Bronchitis

  2000cited by this paper
• The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing.

  2000cited by this paper
• Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.

  2000cited by this paper
• Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid.

  2000cited by this paper
• A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans.

  2000cited by this paper
• Clinical Efficacy of Intravenous followed by Oral Azithromycin Monotherapy in Hospitalized Patients with Community-Acquired Pneumonia

  2000cited by this paper
• Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.

  1999cited by this paper
• The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.

  1999cited by this paper
• [Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint].

  1999cited by this paper
• 呼吸器におけるLevofloxacinの血清, 喀痰および肺組織中濃度の検討:Breakpointからみた有効性の評価

  1999cited by this paper
• Tobramycin penetration into epithelial lining fluid of patients with pneumonia

  1999cited by this paper
• Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.

  1999cited by this paper
• Mode of action of anhydrofulvic acid against Candida utilis ATCC 42402 under acidic condition.

  1999cited by this paper
• Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy.

  1999cited by this paper
• Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.

  1999cited by this paper
• [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].

  1998cited by this paper
• The Pharmacodynamics of β-Lactams

  1998cited by this paper
• Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

  1998cited by this paper
• The pharmacodynamics of aminoglycosides.

  1998cited by this paper
• Pharmacodynamics of fluoroquinolones.

  1998cited by this paper
• The Pharmacodynamics of b-Lactams

  1998cited by this paper
• Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.

  1998cited by this paper
• The pharmacodynamics of beta-lactams.

  1998cited by this paper
• Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

  1998cited by this paper
• Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen for treating acute exacerbations of chronic bronchitis.

  1998cited by this paper
• Pharmacokinetics and Pharmacodynamics of Newer Oral Cephalosporins

  1998cited by this paper
• Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.

  1998cited by this paper
• Expanding indications for the new macrolides, azalides, and streptogramins.

  1997cited by this paper
• A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease.

  1997cited by this paper
• Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy.

  1997cited by this paper
• Antibiotic penetration in the respiratory tract and implications for the selection of antimicrobial therapy

  1997cited by this paper
• Strategies to minimize the development of antibiotic resistance.

  1997cited by this paper
• Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.

  1997cited by this paper
• Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections.

  1997cited by this paper
• Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group.

  1997cited by this paper
• Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.

  1997cited by this paper
• A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses.

  1996cited by this paper
• Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin

  1996cited by this paper
• AUIC — A General Target for the Optimization of Dosing Regimens of Antibiotics?

  1996cited by this paper
• Determination of free extracellular concentrations of piperacillin by microdialysis.

  1996cited by this paper
• Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans

  1996cited by this paper
• Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerations.

  1996cited by this paper
• Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.

  1996cited by this paper
• Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects

  1996cited by this paper
• Pharmacokinetics of antimicrobial agents in the respiratory tract.

  1996cited by this paper
• Outpatient parenteral antibiotic therapy.

  1995cited by this paper
• New concepts in the pulmonary disposition of antibiotics.

  1995cited by this paper
• Pulmonary pharmacokinetics of dirithromycin allow a 5-day treatment of acute bacterial exacerbation of chronic bronchitis

  1995cited by this paper
• Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.

  1995cited by this paper
• Predicting the efficacy of antimicrobial agents in respiratory infections—is tissue concentration a valid measure?

  1995cited by this paper
• Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins.

  1995cited by this paper
• The Penetration of Ceftibuten into the Respiratory Tract

  1995cited by this paper
• Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily

  1995cited by this paper
• Pulmonary penetration of ceftazidime.

  1995cited by this paper
• Beta-Lactam Antibiotics: Is Continuous Infusion The Preferred Method of Administration?

  1995cited by this paper
• Predicting the efficacy of antimicrobial agents in respiratory infections--is tissue concentration a valid measure?

  1995cited by this paper
• Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics.

  1995cited by this paper
• Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis.

  1994cited by this paper
• Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients

  1994cited by this paper
• Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection.

  1994cited by this paper
• Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis.

  1994cited by this paper
• Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage.

  1994cited by this paper
• Problems and prospectives in the antibiotic treatment of lower respiratory tract infections.

  1994cited by this paper
• Respiratory Infections: Diagnosis and Management

  1994cited by this paper
• Antibiotic penetration into lung tissues.

  1994cited by this paper
• Macrolides, chemistry, pharmacology and clinical uses

  1993cited by this paper
• Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.

  1993cited by this paper
• Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic.

  1993cited by this paper
• Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia.

  1993cited by this paper
• Pharmacokinetics of dirithromycin.

  1993cited by this paper
• SELECTING THE ANTIBIOTIC

  1993cited by this paper
• Penetration of netilmicin in the lower respiratory tract after once-daily dosing.

  1992cited by this paper
• Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens.

  1992cited by this paper
• Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.

  1992cited by this paper
• The site concentrations of antimicrobial agents in the lung.

  1992cited by this paper
• Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.

  1992cited by this paper
• Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.

  1992cited by this paper
• Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance

  1992cited by this paper
• Antibiotic pharmacokinetic considerations in pulmonary infections.

  1991cited by this paper
• Intracellular distribution and activity of antibiotics

  1991cited by this paper
• Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro

  1991cited by this paper
• Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

  1991cited by this paper
• Cefaclor in the treatment of chronic bronchitis.

  1991cited by this paper
• Cafaclor in the treatment of chronic bronchitis

  1990cited by this paper
• The pharmacokinetics of the oral cephalosporins--a review.

  1990cited by this paper
• The pharmacokinetics and sputum penetration of ampicillin and amoxycillin following simultaneous i.v. administration.

  1990cited by this paper
• Pharmacokinetics of antibiotics in the lungs.

  1990cited by this paper
• Killing and regrowth of bacteria in vitro: a review.

  1990cited by this paper
• Azithromycin concentrations at the sites of pulmonary infection.

  1990cited by this paper
• Human pharmacodynamics of beta-lactams, aminoglycosides and their combination.

  1990cited by this paper
• Josamycin pulmonary penetration determined by broncho-alveolar lavage in man.

  1988cited by this paper
• Bactericidal effect of ceftriaxone versus imipenem plus cilastatin in bronchial secretion.

  1988cited by this paper

• Pulmonary disposition and pharmacokinetics of a single oral dose of chloramphenicol in healthy fasted adult horses.

  2025cites this paper
• Comparative Pharmacokinetics and Egg Residues of Amoxicillin, Single and in Combination with Bromhexine, in Laying Hens

  2024cites this paper
• Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs

  2021cites this paper
• Status of inhalable antimicrobial agents for lung infection: progress and prospects

  2021cites this paper
• Increased Antimicrobial Activity of Colistin in Combination With Gamithromycin Against Pasteurella multocida in a Neutropenic Murine Lung Infection Model

  2020cites this paper
• Pharmacokinetics and pharmacodynamics of levofloxacin in bronchial mucosa and lung tissue of patients undergoing pulmonary operation.

  2020cites this paper
• Facteurs prédictifs de la pénétration pulmonaire des antibiotiques : évaluation par le dosage des antibiotiques dans le LBA (ABBA)

  2019influential citation
• Use of microdialysis for the assessment of fluoroquinolone pharmacokinetics in the clinical practice

  2019cites this paper
• Drug Selection and Optimization of Dosage Schedules To Minimize Antimicrobial Resistance

  2019cites this paper
• Treatment of Drug-Susceptible Tuberculosis.

  2019cites this paper
• Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers

  2018cites this paper
• Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects

  2017cites this paper
• Bacteria in the respiratory tract-how to treat? Or do not treat?

  2016cites this paper
• Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?

  2015cites this paper
• Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy.

  2015cites this paper
• β-lactam antibiotic pharmacokinetics during continuous venovenous haemofiltration in critically ill patients: continuous infusion versus intermittent bolus administration

  2015cites this paper
• Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients

  2014cites this paper
• Macrolides for macrophages in chronic obstructive pulmonary disease

  2012cites this paper
• Antimicrobial drug concentrations and sampling techniques in the equine lung.

  2012cites this paper
• Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a review

  2011cites this paper
• Diagnosis and management of bacterial pneumonia in adult horses.

  2011cites this paper
• Rapid and prolonged distribution of tulathromycin into lung homogenate and pulmonary epithelial lining fluid of Holstein calves following a single subcutaneous administration of 2.5 mg/kg body weight.

  2010cites this paper
• Antibiotika-Konzentration im Serum und in Bronchialepithel-Flüssigkeit unter kontinuierlicher Infusion

  2010cites this paper
• Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.

  2010cites this paper
• Letter to the Editor

  2009cites this paper
• Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia*

  2008cites this paper
• Sputum antibiotic concentrations: Implications for treatment of cystic fibrosis lung infection

  2007cites this paper
• Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients

  2007cites this paper
• Pharmacokinetics and pharmacodynamics of antibiotics revisited in lungs

  2006cites this paper
• Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.

  2006cites this paper
• Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia

  2006cites this paper
• Pharmacokinetics of azithromycin after i.v. and i.m. administration to sheep.

  2005cites this paper
• Penetration of Orally Administered Prulifloxacin Into Human Lung Tissue

  2005cites this paper
• Pharmacodynamics and the Prediction of Efficacy in Short‐Course Antibiotic Therapy: Pediatric Studies to Validate the Model

  2005cites this paper
• Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis.

  2005cites this paper
• Diffusion pulmonaire des céphalosporines de troisième génération : perfusion continue versus administration intermittente

  2005cites this paper
• Pharmacokinetics and lung tissue concentrations of tulathromycin in swine.

  2004cites this paper